912 related articles for article (PubMed ID: 22155902)
21. Nuclear localization of dengue virus (DENV) 1-4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin.
Tay MY; Fraser JE; Chan WK; Moreland NJ; Rathore AP; Wang C; Vasudevan SG; Jans DA
Antiviral Res; 2013 Sep; 99(3):301-6. PubMed ID: 23769930
[TBL] [Abstract][Full Text] [Related]
22. A quinoline compound inhibits the replication of dengue virus serotypes 1-4 in Vero cells.
Beesetti H; Tyagi P; Medapi B; Krishna VS; Sriram D; Khanna N; Swaminathan S
Antivir Ther; 2018; 23(5):385-394. PubMed ID: 29583121
[TBL] [Abstract][Full Text] [Related]
23. Antiviral activity of an N-allyl acridone against dengue virus.
Mazzucco MB; Talarico LB; Vatansever S; Carro AC; Fascio ML; D'Accorso NB; García CC; Damonte EB
J Biomed Sci; 2015 Apr; 22(1):29. PubMed ID: 25908170
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of dengue virus polymerase by blocking of the RNA tunnel.
Niyomrattanakit P; Chen YL; Dong H; Yin Z; Qing M; Glickman JF; Lin K; Mueller D; Voshol H; Lim JY; Nilar S; Keller TH; Shi PY
J Virol; 2010 Jun; 84(11):5678-86. PubMed ID: 20237086
[TBL] [Abstract][Full Text] [Related]
25. Ten years of dengue drug discovery: progress and prospects.
Lim SP; Wang QY; Noble CG; Chen YL; Dong H; Zou B; Yokokawa F; Nilar S; Smith P; Beer D; Lescar J; Shi PY
Antiviral Res; 2013 Nov; 100(2):500-19. PubMed ID: 24076358
[TBL] [Abstract][Full Text] [Related]
26. Differential proinflammatory and angiogenesis-specific cytokine production in human pulmonary endothelial cells, HPMEC-ST1.6R infected with dengue-2 and dengue-3 virus.
Azizan A; Sweat J; Espino C; Gemmer J; Stark L; Kazanis D
J Virol Methods; 2006 Dec; 138(1-2):211-7. PubMed ID: 17034872
[TBL] [Abstract][Full Text] [Related]
27. Policresulen, a novel NS2B/NS3 protease inhibitor, effectively inhibits the replication of DENV2 virus in BHK-21 cells.
Wu DW; Mao F; Ye Y; Li J; Xu CL; Luo XM; Chen J; Shen X
Acta Pharmacol Sin; 2015 Sep; 36(9):1126-36. PubMed ID: 26279156
[TBL] [Abstract][Full Text] [Related]
28. Antiviral activity of ST081006 against the dengue virus.
Lee JK; Chui JLM; Lee RCH; Kong HY; Chin WX; Chu JJH
Antiviral Res; 2019 Nov; 171():104589. PubMed ID: 31421165
[TBL] [Abstract][Full Text] [Related]
29. Study the antiviral activity of some derivatives of tetracycline and non-steroid anti inflammatory drugs towards dengue virus.
Rothan HA; Buckle MJ; Ammar YA; Mohammadjavad P; Shatrah O; Noorsaadah AR; Rohana Y
Trop Biomed; 2013 Dec; 30(4):681-90. PubMed ID: 24522138
[TBL] [Abstract][Full Text] [Related]
30. Q63, a novel DENV2 RdRp non-nucleoside inhibitor, inhibited DENV2 replication and infection.
Yao X; Guo S; Wu W; Wang J; Wu S; He S; Wan Y; Nandakumar KS; Chen X; Sun N; Zhu Q; Liu S
J Pharmacol Sci; 2018 Dec; 138(4):247-256. PubMed ID: 30518482
[TBL] [Abstract][Full Text] [Related]
31. Identifying initiation and elongation inhibitors of dengue virus RNA polymerase in a high-throughput lead-finding campaign.
Smith TM; Lim SP; Yue K; Busby SA; Arora R; Seh CC; Wright SK; Nutiu R; Niyomrattanakit P; Wan KF; Beer D; Shi PY; Benson TE
J Biomol Screen; 2015 Jan; 20(1):153-63. PubMed ID: 25252731
[TBL] [Abstract][Full Text] [Related]
32. Unfolded protein response (UPR) gene expression during antibody-dependent enhanced infection of cultured monocytes correlates with dengue disease severity.
Paradkar PN; Ooi EE; Hanson BJ; Gubler DJ; Vasudevan SG
Biosci Rep; 2011 Jun; 31(3):221-30. PubMed ID: 20858223
[TBL] [Abstract][Full Text] [Related]
33. Small molecule inhibitor discovery for dengue virus protease using high-throughput screening.
Manzano M; Padia J; Padmanabhan R
Methods Mol Biol; 2014; 1138():331-44. PubMed ID: 24696346
[TBL] [Abstract][Full Text] [Related]
34. The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cell.
Talarico LB; Pujol CA; Zibetti RG; Faría PC; Noseda MD; Duarte ME; Damonte EB
Antiviral Res; 2005 Jun; 66(2-3):103-10. PubMed ID: 15911027
[TBL] [Abstract][Full Text] [Related]
35. Cell-based antiviral assays for screening and profiling inhibitors against dengue virus.
Gong EY; Clynhens M; Ivens T; Lory P; Simmen K; Kraus G
Methods Mol Biol; 2013; 1030():185-94. PubMed ID: 23821269
[TBL] [Abstract][Full Text] [Related]
36. Interferon inhibits dengue virus infection by preventing translation of viral RNA through a PKR-independent mechanism.
Diamond MS; Harris E
Virology; 2001 Oct; 289(2):297-311. PubMed ID: 11689052
[TBL] [Abstract][Full Text] [Related]
37. Characterization of a dengue NS4B inhibitor originating from an HCV small molecule library.
Hernandez-Morales I; Geluykens P; Clynhens M; Strijbos R; Goethals O; Megens S; Verheyen N; Last S; McGowan D; Coesemans E; De Boeck B; Stoops B; Devogelaere B; Pauwels F; Vandyck K; Berke JM; Raboisson P; Simmen K; Lory P; Van Loock M
Antiviral Res; 2017 Nov; 147():149-158. PubMed ID: 29037976
[TBL] [Abstract][Full Text] [Related]
38. A high-throughput assay using dengue-1 virus-like particles for drug discovery.
Qing M; Liu W; Yuan Z; Gu F; Shi PY
Antiviral Res; 2010 May; 86(2):163-71. PubMed ID: 20153777
[TBL] [Abstract][Full Text] [Related]
39. Novel, anionic, antiviral septapeptides from mosquito cells also protect monkey cells against dengue virus.
Laosutthipong C; Kanthong N; Flegel TW
Antiviral Res; 2013 Jun; 98(3):449-56. PubMed ID: 23603496
[TBL] [Abstract][Full Text] [Related]
40. Effect of nitric oxide on Dengue virus replication in Aedes aegypti and Anopheles albimanus.
Ramos-Castañeda J; González C; Jiménez MA; Duran J; Hernández-Martínez S; Rodríguez MH; Lanz-Mendoza H
Intervirology; 2008; 51(5):335-41. PubMed ID: 19023217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
